GSK Gets Offers from Potential Buyers for Romanian Drug Plant

Sep 04, 2013

pharmaceutical-business-review.com

UK-based drug manufacturer GlaxoSmithKline (GSK) has received offers from local and international investors to buy its Europharm factory in Brasov, Romania.

The Brasov facility, which employs about 250 people, is engaged in the manufacturing of drugs for HIV/AIDS treatments, respiratory diseases, depression, cold and flu.

In June, the drugmaker said it was looking for a buyer for the facility in Brasov. GSK said if one could not be found, it would close it. The decision came following a wave of expired patents which led to an excess of capacity for solid oral drugs. Read more

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments